Quant Healthcare Fund - IDCW Option - Regular Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-07-2023
AUM:
388.54 Cr
Expense Ratio
3.14%
Benchmark
Nifty Healthcare TRI
ISIN
INF966L01CH1
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
1000
Fund Manager
Sandeep Tandon, Ankit Pande, Varun Pattani, Ayusha Kumbhat, Yug Tibrewal, Sameer Kate, Sanjeev Sharma
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - IDCW Option - Regular Plan | 18.11 | 19.49 | - |
| NIFTY Healthcare TRI | 13.28 | 20.68 | 14.07 |
If you invested in this fund:
₹
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
17.7753
Last change
-0.16 (-0.8726%)
Fund Size (AUM)
₹ 388.54 Cr
Performance
20.53% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Manager
Sandeep Tandon, Ankit Pande, Varun Pattani, Ayusha Kumbhat, Yug Tibrewal, Sameer Kate, Sanjeev Sharma
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| TREPS 01-Jul-2026 DEPO 10 | 21.73 |
| HFCL LIMITED EQ NEW F.V.RE.1/- | 10.76 |
| Zydus Wellness Ltd | 9.44 |
| ASTER DM HEALTHCARE LIMITED EQ | 8.96 |
| CONCORD BIOTECH LIMITED EQ NEW FV RE.1/- | 8.84 |
| Glenmark Pharmaceuticals Ltd | 8.7 |
| SMS PHARMACEUTICALS LIMITED EQ NEW FV Re.1/- | 8.15 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 7.28 |
| Max Healthcare Institute Limited | 5.8 |
| Divis Laboratories Limited | 5.74 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 50.81 |
| Telecommunication | 10.76 |
| Fast Moving Consumer Goods | 9.44 |